1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6C986A51F659E07DE002587E600380872
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/C986A51F659E07DE002587E600380872?OpenDocument
18
19OpenDocument
2018.207.240.77
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Patient Focused Services Patient Insights

Document Excerpt: Improving Patient Medication Adherence Metrics: Adherence, Persistence, and Compliance Rates

DB Image

Excerpt in Cart

ID: MD-816


Features:

13 Info Graphics

15 Data Graphics

90+ Metrics

10 Narratives


Pages/Slides: 4


Published: 2022


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5716 “Improving Patient Medication Adherence Metrics: Adherence, Persistence, and Compliance Rates”.

Industries Profiled:
Consulting; Pharmaceutical; Biopharmaceutical; Biotech; Chemical; Health Care; Communications; Consumer Products; Medical Device


Companies Profiled:
Coeus Consulting; Daiichi Sankyo; Eli Lilly; Emmaus Life Sciences; Genentech; GlaxoSmithKline ; Jazz Pharmaceuticals; Medunik; Myovant Sciences; NexGen Healthcare Communications; Novartis; Novo Nordisk; Patheon; Priovant Therapeutics; Roche; Sandoz; Servier; Spectrum Pharmacy Products; Teva Pharmaceutical Industries Ltd; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.